drugset / Trial / NCT04524052
To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to assess the safety, tolerability, pharmacodynamics, and pharmacokinetics of Niclosamide (DWRX2003) following escalating doses of DWRX2003 administered as an intramuscular injection in healthy volunteers.
Timeline
- Start
- 2020-08
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWRX2003 | Unknown | 144 mg | Intramuscular |
| Subject | DWRX2003 | Unknown | 432 mg | Intramuscular |
| Subject | DWRX2003 | Unknown | 960 mg | Intramuscular |
| Subject | DWRX2003 | Unknown | 1200 mg | Intramuscular |
Indications
No indication recorded.